News tagged with generic medicines

Six medication myths busted

Can pain relievers really target a specific part of the body? Are generic medicines inferior to their brand-name counterparts? Are natural medicines always safer then prescription drugs? Can you mix alcohol with a prescription ...

Oct 13, 2014
popularity 5 / 5 (3) | comments 0

$580 million EU antitrust fine for drug makers

The European Union's antitrust body is imposing a fine of 428 million euros ($580 million) on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.

Jul 09, 2014
popularity not rated yet | comments 0

Challenges to equitable access to medicines

(Medical Xpress)—Access to medicines by vulnerable groups in the community, increasing medicine costs, and the demand for new medicines are some of the challenges identified in an independent study of priority medicine ...

Jun 11, 2014
popularity not rated yet | comments 0

S.Africa tackles drugs patent reform

South Africa's government has published a draft intellectual property policy with potential far-reaching effects for pharmaceutical patents, which rights groups hailed Monday as a move towards lower medicine costs.

Sep 09, 2013
popularity not rated yet | comments 0

Indian firm unveils latest typhoid shots

An Indian pharmaceutical firm said Thursday it would soon launch the world's first vaccine against typhoid which can be given to infants, protecting the most vulnerable victims of the illness.

Aug 29, 2013
popularity not rated yet | comments 0

Pfizer 2Q mixed, maintains 2013 outlook

Pfizer's second-quarter net income more than quadrupled, helped by the sale of its animal health business. The world's second-largest drugmaker beat Wall Street's earnings expectations, though revenue continued to decline ...

Jul 30, 2013
popularity not rated yet | comments 0

More pain for Japan's Daiichi hit by Ranbaxy fraud

Daiichi Sankyo believed it had scored a coup in 2008 when it outbid rivals to buy Indian generics giant Ranbaxy for $4.6 billion but its foray into the high-growth copycat drugs arena has brought the Japanese drugmaker only ...

Jun 09, 2013
popularity not rated yet | comments 0